Clinical Trials Logo

Clinical Trial Summary

The primary objective of the study was to assess the appropriateness of antiviral therapy with nirmatrelvir-ritonavir in hospitalized patients.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05749445
Study type Observational
Source First People's Hospital of Hangzhou
Contact Changcheng Shi
Phone 86-13967157030
Email cpushicc@163.com
Status Recruiting
Phase
Start date December 15, 2022
Completion date April 2023

See also
  Status Clinical Trial Phase
Recruiting NCT04112745 - The Effect of Magnetic Therapy on Pain Relief in Postoperation Patients N/A
Completed NCT02959632 - Animal Assisted Therapy Intervention for Hospitalized Patients in a Tertiary Care Center N/A
Completed NCT03354468 - The Effects of a Fall Prevention Program on Falls, Patient Safety Culture and Patient-perceived Safety
Completed NCT03224130 - Supplement to Hospital to Home Outcomes N/A
Completed NCT00520715 - Epidemiology of Fluoroquinolone Resistance in Human Commensal Flora in Patients Hospitalised in Medical Wards N/A
Completed NCT06403826 - SHIFT Hospital in Motion (Pilot Study)
Completed NCT04310332 - 1L- vs. 4L-PEG for Bowel Preparation Among Inpatients.
Completed NCT04787510 - COVID-19 Disease and Coagulopathy: Assessment of Clotting Factor Levels in Patients With SARS-CoV-2 Infection
Not yet recruiting NCT04520880 - Antibodies Responses to COVID-19 Infection in Hospitalized Patients
Terminated NCT02119000 - Comparison of Two Types of Bowel Preparation for Inpatient Colonoscopy Phase 4
Completed NCT04401150 - Lessening Organ Dysfunction With VITamin C - COVID-19 Phase 3
Recruiting NCT06396676 - SHIFT-Hospital in Motion (Validation Study)